Transforming growth factor β1 in the human endometrium.: Cyclic variation, increased expression by estradiol and progesterone, and regulation of plasminogen activators and plasminogen activator inhibitor-1

被引:50
作者
Casslén, B
Sandberg, T
Gustavsson, B
Willén, R
Nilbert, M
机构
[1] Univ Lund Hosp, Dept Obstet & Gynecol, S-22185 Lund, Sweden
[2] Univ Lund Hosp, Dept Pathol, S-22185 Lund, Sweden
[3] Univ Lund Hosp, Dept Oncol, S-22185 Lund, Sweden
关键词
D O I
10.1095/biolreprod58.6.1343
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The purpose of this study was to identify cyclic variations and hormonal regulation of endometrial transforming growth factor beta 1 (TGF beta 1) mRNA. Regulation of the plasminogen-activating system was also examined, since it is involved in activation of latent TGF beta s. We measured TGF beta 1 mRNA in 51 normal endometrial samples by Northern blot and densitometric scanning of autoradiograms. Each value was related to the corresponding beta-actin value to allow quantitative evaluation. TGF beta 1 mRNA was higher in the mid and late secretory and menstrual phases than in the earlier parts of the cycle. This pattern implies progesterone dependence. The content of TGF beta 1 mRNA in endometrial tissue explants obtained in the proliferative phase was significantly increased after stimulation for 4 days with estradiol + progesterone in vitro. Both TGF beta 1 and estradiol + progesterone increased the content of plasminogen activator inhibitor-1 mRNA and protein in primary cultures of endometrial stromal cells. Conditioned-medium concentrations of urokinase plasminogen activator (u-PA) were increased by TGF beta 1, but decreased by estradiol + progesterone. This effect of estradiol + progesterone results from increased internalization and degradation of u-PA secondary to up-regulation of the cell surface receptor for u-PA by progesterone (Casslen et al., JCEM 1995; 80: 2776-2784). Increased extracellular u-PA in response to TGF beta 1 exposure was thus in concordance with an unchanged amount of available u-PA receptors on the cell surface. The activation mechanism of latent TGF beta involves u-PA activity; since u-PA activity is reduced in the secretory endometrium, we suggest that although TGF beta 1 mRNA is increased in the mid and late secretory phase, TGF beta s are mainly in their latent form until the premenstrual rise in u-PA activity stimulates activation. TGF beta may promote capillary growth during endometrial regeneration.
引用
收藏
页码:1343 / 1350
页数:8
相关论文
共 51 条
  • [1] TRANSFORMING GROWTH-FACTOR-BETA INHIBITS PLASMINOGEN-ACTIVATOR (PA) ACTIVITY AND STIMULATES PRODUCTION OF UROKINASE-TYPE PA, PA INHIBITOR-1 MESSENGER-RNA, AND PROTEIN IN RAT OSTEOBLAST-LIKE CELLS
    ALLAN, EH
    ZEHEB, R
    GELEHRTER, TD
    HEATON, JH
    FUKUMOTO, S
    YEE, JA
    MARTIN, TJ
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1991, 149 (01) : 34 - 43
  • [2] PLASMINOGEN-ACTIVATOR INHIBITORS - HORMONALLY REGULATED SERPINS
    ANDREASEN, PA
    GEORG, B
    LUND, LR
    RICCIO, A
    STACEY, SN
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1990, 68 (01) : 1 - 19
  • [3] Modulation of the levels of transforming growth factor beta messenger ribonucleic acids in human endometrial stromal cells
    Arici, A
    MacDonald, PC
    Casey, ML
    [J]. BIOLOGY OF REPRODUCTION, 1996, 54 (02) : 463 - 469
  • [4] THE UROKINASE RECEPTOR - STRUCTURE, REGULATION AND INHIBITOR-MEDIATED INTERNALIZATION
    BLASI, F
    CONESE, M
    MOLLER, LB
    PEDERSEN, N
    CAVALLARO, U
    CUBELLIS, MV
    FAZIOLI, F
    HERNANDEZMARRERO, L
    LIMONGI, P
    MUNOZCANOVES, P
    RESNATI, M
    RIITTINEN, L
    SIDENIUS, N
    SORAVIA, E
    SORIA, MR
    STOPPELLI, MP
    TALARICO, D
    TEESALU, T
    VALCAMONICA, S
    [J]. FIBRINOLYSIS, 1994, 8 : 182 - 188
  • [5] TRANSFORMING GROWTH-FACTOR-BETA MEDIATES THE PROGESTERONE SUPPRESSION OF AN EPITHELIAL METALLOPROTEINASE BY ADJACENT STROMA IN THE HUMAN ENDOMETRIUM
    BRUNER, KL
    RODGERS, WH
    GOLD, LI
    KORC, M
    HARGROVE, JT
    MATRISIAN, LM
    OSTEEN, KG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) : 7362 - 7366
  • [6] REGULATION OF PARATHYROID HORMONE-RELATED PROTEIN GENE-EXPRESSION IN HUMAN ENDOMETRIAL STROMAL CELLS IN CULTURE
    CASEY, ML
    MIBE, M
    MACDONALD, PC
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (01) : 188 - 194
  • [7] FIBRINOLYTIC-ACTIVITY OF HUMAN UTERINE FLUID
    CASSLEN, B
    ASTEDT, B
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1981, 60 (01) : 55 - 58
  • [8] EXPRESSION OF CELL-MEMBRANE RECEPTORS FOR UROKINASE PLASMINOGEN-ACTIVATOR (U-PA) IN THE HUMAN ENDOMETRIUM INCREASES DURING THE OVARIAN CYCLE
    CASSLEN, B
    GUSTAVSSON, B
    [J]. FIBRINOLYSIS, 1991, 5 (04) : 243 - 248
  • [9] EFFECT OF IUD ON UROKINASE-LIKE IMMUNOREACTIVITY AND PLASMINOGEN ACTIVATORS IN HUMAN UTERINE FLUID
    CASSLEN, B
    THORELL, J
    ASTEDT, B
    [J]. CONTRACEPTION, 1981, 23 (04) : 435 - 445
  • [10] PROGESTERONE STIMULATES DEGRADATION OF UROKINASE PLASMINOGEN-ACTIVATOR (U-PA) IN ENDOMETRIAL STROMAL CELLS BY INCREASING ITS INHIBITOR AND SURFACE EXPRESSION OF THE U-PA RECEPTOR
    CASSLEN, B
    NORDENGREN, J
    GUSTAVSSON, B
    NILBERT, M
    LUND, LR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (09) : 2776 - 2784